Deferred Tax Assets, Operating Loss Carryforwards in USD of Kairos Pharma, LTD. from Q4 2023 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Kairos Pharma, LTD. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and change rate from Q4 2023 to Q4 2024.
- Kairos Pharma, LTD. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2024 was $1,199,000, a 40% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)